Individuals with social risk factors at the time of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have increased risk for subsequent long COVID.

Patients with psoriasis who have high levels of serum 25-hydroxyvitamin D have a decreased risk for incident cardiovascular disease and mortality.

There is lower incidence of nonlacunar covert infarcts among patients with cryptogenic stroke and atrial cardiopathy treated with apixaban.

MASLD rates have decreased, whereas liver fibrosis and cirrhosis rates have increased among US patients with type 2 diabetes since 2017.

Maternal hypertension is linked to poorer cognitive, language outcomes in preterm 2-year-olds, partly due to early brain abnormalities.

There is decreased risk for MACE and all-cause mortality in dialysis-dependent patients with ASCVD who are treated with statins.

Dr Samantha Philip and Dr Kathryn E Kyler discuss the impact of weight bias in healthcare and ways for physicians to be more weight inclusive.

A new diabetes subtype has been identified in Sub-Saharan Africans and Black Americans, according to a study published online.

Treatments for acromegaly, edema, HSCT-associated thrombotic microangiopathy, multiple sclerosis, and spinal muscular atrophy are under review.

The FDA has approved a labeling update for Leqvio (inclisiran) allowing for first-line use in the treatment of hypercholesterolemia.

Vitamin D insufficiency and deficiency are tied to higher risk of being hospitalized for COVID-19, according to a study published online.

Polygenic scores (PGSs) for body mass index (BMI) can improve obesity prediction, according to a study published online.